Forty nine patients with rectosigmoid carcinoma considered unsuitable for surgery underwent endoscopic Nd:YAG laser treatment for paliiation of symptoms and tumour eradication, if feasible. Altogether 25 (51%) of the lesions had distal margins less than 7 cm from the anus and 36 (73%) extended above the peritoneal reflection. In seven patients with tumours less than 3 cm in diameter, symptomatic improvement was achieved in all (mean follow up 16 months) and complete tumour eradication in three. In the remaining 42 patients with larger tumours (34 greater than 2/3 circumferential, mean length 55 cm), symptomatic improvement was achieved with repeated treatments (average 3.4) in 31 (74%) over a mean follow up of 19 weeks. Of the parameters assessed, only circumferential tumour extent proved significant in predicting functional outcome after treatment. All treatment failures (eight initial, three late) occurred in patients with extensive tumours, and only seven of these patients were considered fit for colostomy. Bowel perforation occurred in two patients (5%) but there was no treatmentrelated mortality. Mean stay in hospital for all laser treatments was nine days (30% were outpatient attendances). These results suggest that laser therapy may be the palliative treatment of choice in patients with rectal carcinoma unsuitable for surgery.
palliative efficacy." The present study presents the initial and longterm results of palliative Nd:YAG laser therapy in 49 patients treated in our unit and attempts to analyse the importance of several patient and tumour parameters as determinants of functional outcome.
Materials and methods

PATIENT POPULATION
Forty nine patients with rectosigmoid adenocarcinomas received endoscopic laser therapy at the National Medical Laser Centre in the three year period 1985-8. They were referred because of incurable disease (documented distal metastases or advanced locoregional disease), high surgical risk (advanced age, severe cardiorespiratory disease), or refusal of surgery. Patients were divided into two groups according to tumour size. Those with tumours less than 3 cm in maximum diameter and less than 1/3 circumferential were allocated to group 1; patients with larger lesions were allocated to group 2. Patient details, symptomatic presentation, and reasons for laser therapy in the two groups are shown in Table I Advanced local disease 0 16 High surgical risk/refusal of surgery 7 7
RD=rectal discharge. In addition, it seems that the longterm efficacy of laser therapy is less if patients are retreated at longer time intervals after the development of recurrent symptoms,9 as discussed below.
PATIENT EVALUATION Group 1. In asymptomatic patients, treatment was considered successful if complete macroand microscopic eradication of the tumour was achieved. In those presenting with rectal discharge or tenesmus, treatment was deemed successful if they were rendered completely asymptomatic.
Group 2. Evaluation of the effect of treatment in this group of patients is more difficult and to a great extent subjective, especially in those presenting with rectal discharge, haemorrhage, incontinence, and tenesmus. Pain caused by local pelvic infiltration cannot be palliated by laser therapy and has not been assessed. In a previous report,4 we attempted to quantify objectively these symptoms, and others have done likewise.'9 Our subsequent experience, however, has shown that this is extremely difficult to perform especially in elderly, terminally ill patients who are seldom able to give a reliable objective account of their symptoms. For the patients described in this report we have used a more subjective assessment -laser therapy was considered successful if symptoms caused by intraluminal tumour were reduced to an extent that enabled the patient to lead a lifestyle appropriate for his or her age and general condition without constant concern for bowel function. Thus treatment success depended on both the patient's subjective symptomatic assessment and attitude towards these symptoms. In patients with predominantly obstructive symptoms, clinical examination findings and the degree of colonic faecal loading on a plain abdominal radiograph were used in addition to subjective symptomatic assessment to assess treatment success.
STATISTICS
Statistical analyses were performed using a X test with Yates's correction and Mann-Whitney U test. Survival and symptom palliation interval distributions were calculated using the life table method and tested for disparity by log rank analysis. For the calculation of these distributions, patients dying palliated were censored (that is, lost to follow up).
Results
GROUP I
Complete resolution of symptoms was achieved in all four patients presenting with rectal discharge with or without tenesmus and was maintained until death, which occurred from unrelated disease at 13, 15, 16, and 20 months respectively after entry into the study. Complete macroscopic and microscopic tumour eradication was possible in only one of these four patients.
In the three asymptomatic patients, complete tumour destruction with negative biopsy specimens was achieved in two. The patient with At least 60% of group 2 patients in our study would have required a permanent colostomy had they been managed surgically and laser therapy avoided the need for this in 74% of these patients. Two thirds of the treatment failures in the subgroup with discharge and anal incontinence at presentation were functional with persistent symptoms despite adequate tumour ablation. All these patients had low rectal tumours and tumour invasion of the anal sphincter mechanism may have been responsible for the lack of improvement. The Endoscopic laser photoablation should be considered as the palliative treatment of choice in patients with rectal carcinoma not suitable for surgery. It is applicable to lesions both above and below the peritoneal reflection and provides good longterm symptomatic control in a high percentage of patients, with a low morbidity and mortality unparalleled by any of the rival treatment methods. Laser therapy could also be used as an alternative to palliative surgery in some patients with incurable disease given the significant morbidity and mortality of the latter. As complete eradication of small tumours (less than 3 cm diameter) is possible in virtually 100% of patients with these, curative local laser treatment should be considered in highly selected patients. 
